Skip to content

Clinical trials

Completed Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Completed Country / region: Singapore Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20072
20092
20105
20113
20122
20136
20143
20157
20164
20175
20183
20193
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer8
GlaxoSmithKline4
National Cancer Centre, Singapore4
Novartis Pharmaceuticals4
Celgene2
Hoffmann-La Roche2
National University of Singapore2
Sanofi2
Sumitomo Pharma America, Inc.2
AO Innovation Translation Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms51
Breast Neoplasms8
Neoplasms by Site8
Carcinoma, Non-Small-Cell Lung7
Neoplasm Metastasis7
Neoplasms by Histologic Type6
Adenocarcinoma5
Colorectal Neoplasms5
Digestive System Diseases5
Digestive System Neoplasms5

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.